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Abstract: This paper explores the recent literature surrounding comorbid depression and 
COPD. The literature reveals a high prevalence of depression in patients with COPD and some 
evidence that the depression is a result of the disease. The literature highlights the negative 
impact of depression on quality of life and a possible impact on mortality. Depression also 
negatively impacts on compliance and smoking cessation. Treatment of depression in COPD, 
particularly by cognitive behavioral therapy, has positive impact on quality of life. Tricyclic 
antidepressants have a positive impact on mood and COPD, but side effects limit their use. The 
advent of the new antidepressants may improve acceptability and outcomes, but the research is 
yet to be undertaken. Physical rehabilitation may have a positive impact on mood. This paper 
highlights the difﬁ  culty in screening for depression in patients with COPD due to the overlap 
of symptoms between the two diseases. Despite the difﬁ  culties, it is important to recognize and 
treat depression in patients with COPD because of the signiﬁ  cant likelihood of improvement 
in quality of life.
Keywords: depressive disorder, chronic obstructive pulmonary disease, patient compliance, 
smoking cessation
Introduction
Chronic obstructive pulmonary disease is a common chronic lung disease that has 
a signiﬁ  cant impact on the quality of life of those with the condition. It impacts on 
patients’ lives through restriction of activities, interference with sleep, and limitation 
of social life. It is not surprising that COPD signiﬁ  cantly affects the sufferer’s mental 
health. The association between COPD and anxiety and depression is well recognized. 
This paper explores recent research highlighting the impact of COPD on mood and 
vice versa. It is based on the author’s knowledge of the literature surrrounding the 
interaction between depression and chronic disease, supplemented by a search of 
MEDLINE for literature relating to depression or depressive disorder and “pulmonary 
disease, chronic obstructive”.
Prevalence
There is a well documented association between COPD and anxiety or depression 
(Dowson et al 2001; Mikkelsen et al 2004; Kunik et al 2005). In respiratory clinics, 
the prevalence of depression is around 40% (de Godoy DV and de Godoy RF 2003; 
Stage et al 2003; Yohannes et al 2003), while in the emergency department and 
general practice it is lower (12%, Dahlen and Janson 2002; and 21.6%, van Manen 
et al 2002). In general practice, there seems to be a relationship between depression 
and the severity of the COPD, with 25% of patients with severe COPD also having 
depression, 19.6% of those with mild COPD, and 17.5% of those in the control 
group (van Manen et al 2002). In all of the above studies, standard instruments 
(such as Hamilton and Beck depression scores) were used to make the diagnosis 
of depression. This is important, as the recognition and diagnosis of depression 
in nonpsychiatrist practitioners is limited, especially at an isolated consultation 
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(Bushnell 2004). The high prevalence of depression in 
patients attending a respiratory clinic is not unexpected, 
as the majority of patients will have more severe COPD 
than that seen regularly in the general practice setting. 
This argument assumes that the depression is caused by 
the COPD (see below).
All of the above prevalence rates were determined by 
diagnostic instruments. Whether screening for depression 
should be undertaken in patients with COPD also depends 
on the impact of the disease, its ease of treatment, and the 
impact of the treatment. As demonstrated below, the recogni-
tion and treatment of depression should lead to signiﬁ  cant 
improvements in quality of life.
Impact of depression on COPD
In patients with COPD seen in the emergency department, 
the presence of anxiety or depression was associated with 
signiﬁ  cantly higher admission rates (52% of patients with 
anxiety or depression compared with 19% of those without; 
Dahlen and Janson 2002). This suggests that depression and 
anxiety occur in patients with more severe COPD, or that 
depression and anxiety lead to a worsening of the COPD. In 
the same study, patients requiring readmission had higher 
scores on the Hospital Anxiety and Depression (HAD) scale 
than patients not requiring readmission.
In an outpatient population, the presence of depression 
or anxiety led to a doubling of the number of days admitted 
to hospital (Mikkelsen et al 2004). Depression was a better 
predictor of reduction in activities of daily living than forced 
expiratory volume in 1 second (FEV1) (Yohannes et al 2003). 
In some studies, depression, among other factors, has been 
associated with higher mortality (Almagro et al 2002), but 
this has not been found in all studies (Yohannes et al 2002). 
Depression in patients with COPD has a signiﬁ  cant detri-
mental impact on quality of life (QOL) (Clary et al 2002). 
A small study in the elderly demonstrated that the reduction 
in FEV1 had the biggest impact on QOL, but mood was also 
important (Peruzza et al 2003).
Depression also has other impacts on patients with COPD. 
Sleep disturbance is common in COPD, and patients with 
COPD and depression or arthritis are more likely to have 
disturbed sleep (Bellia et al 2003). In patients on long-term 
oxygen therapy, depression was associated with de-creased 
preference for resuscitation (50% not for resuscitation in 
depressed patients compared with 23% in nondepressed 
patients; Stapleton et al 2005). The depression did not have 
any effect on the preference for mechanical ventilation.
The impact of COPD on depression
There have been limited studies of the impact of COPD on 
depression. Pulmonary rehabilitation programs can result 
in improvement of depression (Kozora et al 2002; Garuti 
et al 2003; Goldberg et al 2004). Other studies have not 
demonstrated this (de Godoy DV and de Godoy RF 2003). 
Whether this is due to improved physical wellbeing, involve-
ment in group activities, or improvement in oxy-genation is 
unknown.
In the literature on asthma, there is evidence that QOL in 
patients with asthma and depression is worse than in those 
patients suffering either alone (Goldney et al 2003). There 
is also evidence in this literature that symptoms may reﬂ  ect 
depression severity rather than asthma severity (Rimington 
et al 2001). Whether these ﬁ  ndings also apply to COPD has 
not been studied.
Treatment of depression in COPD
The treatment of depression in patients with COPD has 
been the subject of a number of reviews (Clary et al 
2002; Mikkelsen et al 2004) that have demonstrated the 
effectiveness of tricyclic antidepressant (TCA) medi-
cation in improving mood but with little effect on the 
COPD. Because of the side effects of TCA there has been 
a reticence to use them (Clary et al 2002). The advent 
of selective serotonin reuptake inhibitors (SSRIs) may 
change this, but so far the studies have been very limited 
(Clary et al 2002).
Several reviews of cognitive behavioral therapy (CBT) 
(Clary et al 2002; de Godoy DV and de Godoy RF 2003; 
Mikkelsen et al 2004) have demonstrated its effectiveness 
in improving physical as well as psychological wellbeing. 
These reviews have supported the use of CBT as an adjunct 
to pulmonary rehabilitation.
The positive impact of improving mood in response to 
rehabilitation suggests that the diminished mood may be 
secondary to COPD. A difﬁ  culty arises in that at least some 
of the symptoms of depression, as measured in depression 
rating instruments, may arise from the COPD itself. Tired-
ness, lack of energy, weight loss, and disturbed sleep are 
symptoms of both conditions.
The diminished cognition and mental slowing may 
be attributable to hypoxia (Clary et al 2002; Mikkelsen 
et al 2004), and depression itself may be secondary to 
corticosteroid administration (Mikkelsen et al 2004). 
Treatment of COPD may improve the hypoxia and lead to a 
reduction in corticosteroid administration. The association International Journal of COPD 2006:1(1) 63
COPD and depression
of mood with corticosteroid administration is complex, with 
several possible outcomes. Clinical experience suggests that 
a signiﬁ  cant number of people taking corticosteroids have 
an improvement in their mood, yet drug-induced psychosis 
is also seen. People who are on reducing doses of cortico-
steroid medication may develop tiredness and joint pains. 
The impact of corticosteroids in the individual patient is 
idiosyncratic.
Cause and effect
There have been few longitudinal studies of the development 
of depression in patients with COPD. The major study, the 
Health and Retirement Study (Polsky et al 2005), followed 
8387 adults aged 51–61 years for 10 years. Subjects were 
reevaluated biennially. Part of this study examined the occur-
rence of depressive symptoms after the diagnosis of one of 
seven medical conditions. Chronic lung disease (excluding 
asthma) was included in the analysis. Within two years of 
diagnosis the hazard ratio for the development of depressive 
symptoms was 2.21 (95% conﬁ  dence interval 1.64–2.97). 
This compares with 3.55 for cancer and 1.45 for heart disease. 
Depressive symptoms developed 2–4 years after the diag-
nosis of inﬂ  ammatory arthritis. The Health and Retirement 
Study supports the idea that depression in COPD develops 
in response to the diagnosis of the disease.
COPD, depression, and smoking
A number of studies have demonstrated that patients with 
COPD who also suffer from depression or anxiety are 
more likely to be smokers (van Manen et al 2002; Wagena 
et al 2004). The primary association appears to be between 
depression and smoking (Almeida and Pfaff 2005; Gulec 
et al 2005). Anecdotally, psychiatrists report that cigarette 
smoking appears to have an antidepressant effect. Generally, 
depression severely limits the effectiveness of smoking 
cessation programs (Cinciripini et al 2003; Freedland 
et al 2005).
Depression and compliance
On theoretical grounds, it has been assumed that depression 
is associated with poor compliance. This has been conﬁ  rmed 
in studies that relate to asthma treatment. In a prospective 
study, poor compliance (taking less than 70% of inhaled 
medication) was associated with higher depression scores at 
commencement of the study (Bosley et al 1995). Although 
anxiety levels were also high, anxiety was not associated 
with poor compliance. It is possible to postulate that anxiety 
actually improves compliance, by focusing the patient on 
their disease and its treatment. Other cross-sectional stud-
ies have conﬁ  rmed the ﬁ  ndings of poor compliance being 
associated with higher levels of depression (Cluley and 
Cochrane 2001).
Screening for depression
Most of the studies described previously have used diag-
nostic instruments to diagnose depression. A few have used 
the “gold standard” of psychiatric interview. There have not 
been any studies of screening instruments.
In the general literature on depression there have been 
some attempts at developing screening tools, but these have 
not always been successful. The most commonly exam-
ined screening instruments are the one and two question 
screens (Whooley et al 1997; Arroll et al 2003; Henkel et 
al 2004). These studies demonstrate that the two questions, 
which relate to the two essential criteria for the diagnosis of 
depression, are effective. However, preliminary work (Reddy 
et al 2005) indicates that such screening tests are ineffective 
in patients with chronic diseases. Tiredness, low energy, 
weight loss, and loss of interest occur in both depression 
and COPD.
It would seem that instruments such as the Beck Depres-
sion Inventory or the Hamilton Depression scale are required. 
Unfortunately, these require some time for the patient to 
complete and the practitioner to interpret. Using them in busy 
clinical practice as screening instruments is not practical. It 
would seem appropriate that screening tests for depression 
in patients with COPD still need to be devised.
Conclusions
Depression is common in patients with COPD, and its pres-
ence has a signiﬁ  cant impact on the QOL of such patients 
and may be associated with a higher mortality rate. It also 
negatively affects compliance and smoking cessation.
Depression responds to treatment and the literature sug-
gests that cognitive behavioral therapy may be the treatment 
of choice. Further research is required to determine the 
impact of SSRIs in the treatment of depression in patients 
with COPD and the cost beneﬁ  t of screening for depres-
sion in patients in different settings. Care needs to be taken 
in developing screening tests for depression in patients
with COPD.International Journal of COPD 2006:1(1) 64
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